Enzymotec (ENZY) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Enzymotec Ltd. Reports First Quarter 2015 Unaudited Financial Results
May 7, 2015 7:30 AM EDTMIGDAL HA'EMEQ, Israel, May 7, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq: ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported financial results for the first quarter ended March 31, 2015.
First Quarter 2015 Financial Highlights
The Company continues its recovery as revenues and adjusted EBITDA increased for the third consecutive quarter on a sequential basis. First quarter net revenues (equity method) increased 4.8% compared to the fourth quarter of 2014, but decreased 36.7% to $11.3 million, compared to the first quarter of 2014. First quarter net revenues (proportionate consolidation method) increased 1.1%... More